In This Story LLY +0.84% NVO +1.01% HIMS +5.66% Eli Lilly ( LLY +0.84% ), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday warning patients about off-brand versions of its treatments, saying “they put people at risk.” Suggested Reading Elon Musk's DOGE could hurt the U.S. economy, Bank of America says Tesla stock is set for its second-worst month ever as Elon Musk's investors turn jittery Starbucks is cutting menu items so say goodbye to

Tag-uri: Advertising